Clinical Trials in Minneapolis

Showing 8821-8840 of 14,456 trials

Post-Approval Prospective Study - Conventus CAGE™ PH for Use in Proximal Humerus Fracture Fixation

NCT03489408

The purpose of this study is to collect device and procedure experience in everyday clinical practice. The patients are being asked to participate in this study because they are a surgical candidate for the treatment of a broken shoulder and are considering treatment with the PH Cage device.

Humeral Fractures, Proximal

Conventus Orthopaedics, Inc.40 participantsStarted Feb 2018

Redwood City, California, United States • Torrance, California, United States • Baltimore, Maryland, United States +2 more locations

COMPLETEDPhase 1/2< 1 mile

ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL

NCT02141451

This is a single institution phase I/II study using an ADAM17 inhibitor (INCB7839) with rituximab as consolidation therapy after an autologous hematopoietic cell transplant (HCT) for patients with diffuse large B cell lymphoma (DLBCL). The study consists of two phases. The dose finding phase is a modified version of a phase I trial and the extended phase is a modified version of a phase II trial.

Diffuse Large B Cell Non-Hodgkin Lymphoma

Masonic Cancer Center, University of Minnesota30 participantsStarted May 2014

Minneapolis, Minnesota, United States

COMPLETEDPhase 2< 1 mile

A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma

NCT01498328

The purpose of this research study is to find out whether adding an experimental vaccine called rindopepimut (also known as CDX-110) to the commonly used drug bevacizumab can improve progression free survival (slowing the growth of tumors) of patients with relapsed EGFRvIII positive glioblastoma.

GlioblastomaSmall Cell GlioblastomaGiant Cell Glioblastoma+4 more

Celldex Therapeutics127 participantsStarted Dec 2011

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +42 more locations

Post-Approval Prospective Study - Conventus CAGE™ PH for Use in Proximal Humerus Fracture Fixation

ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL

A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma

Find Trials by Condition in Minneapolis

A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study

Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis

A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)

Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer

A Phase 3 Study of Tanezumab for Chronic Low Back Pain

Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window

A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab

S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping

Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes

Safety and Biological Activity of Vesatolimod in HIV-1 Infected, Virologically Suppressed Adults

G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes

Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency

Enhancing the Public Health Impact of Latent Tuberculosis (TB) Infection Diagnosis and Treatment